Details for 2005016875

Up to date per 05.04.2026

Actions

Title / Product Name

Verwendung von einer oralen Suspension enthaltend Megestrolacetat zur Behandlung von Asthma bronchiale

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2005016875

EP Publication Number

1749531

E-Number

737485

Language

PCT Number

Publication Date

07.02.2007 A

22.07.2015 B1

Registration Date

22.07.2015

AT Publication Date

15.08.2015

Application Date

03.08.2005

Registration Number

Priorities

IPC

A61K 31/57 20060101AFI20141127BHEP

Maximum Duration of Protection

03.08.2025

Owner

Par Pharmaceuticals, Inc.300 Tice Boulevard Woodcliff Lake, NJ 07677US

Representative

No representatives present

Inventor

Anker, StefanMahlerstrasse 13 13088 BerlinDE

Springer, JochenMainstrasse 1b 14612 FalkenseeDE